Carbamazepine clearance and seizure stability during pregnancy

Epilepsy and Behavior

Volumn 33, Issue , 2014, Pages 49-53

  Johnson, Emily L ^a   Stowe, Zachary N ^b   Ritchie, James C ^d   Newport, D Jeffrey ^c   Newman, Melanee L ^d   Knight, Bettina ^b   Pennell, Page B ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Carbamazepine; Clearance; Epilepsy; Free carbamazepine; Pregnancy; Seizure

Indexed keywords

CARBAMAZEPINE; CARBAMAZEPINE 10,11 OXIDE; ANTICONVULSIVE AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; CONCEPTION; DISEASE ASSOCIATION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG MONITORING; DRUG RESPONSE; FEMALE; HUMAN; MIDDLE AGED; MONOTHERAPY; OBSERVATIONAL STUDY; PREGNANCY; PROSPECTIVE STUDY; SEIZURE; THIRD TRIMESTER PREGNANCY; YOUNG ADULT; EPILEPSY; PREGNANCY COMPLICATIONS;

ADULT; ANTICONVULSANTS; CARBAMAZEPINE; EPILEPSY; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS; PROSPECTIVE STUDIES;

EID: 84896048598     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2014.02.011     Document Type: Article

References (17)

1. Harden C.L., Pennell P.B., Koppel B.S., Hovinga CA, Gidal B, Meador KJ, et al. Practice parameter update: management issues for women with epilepsy-focus on pregnancy (an evidence-based review): vitamin K, folic acid, blood levels, and breastfeeding. Neurology 2009, 73:142-149.
2. International League Against Epilepsy Worldwide AED database Available at:, [Accessed 2/1/13]. http://www.ilae.org/Visitors/Centre/AEDs/index.cfm.
3. Hernandez-Diaz S., Smith C.R., Shen A., Mittendorf R, Hauser WA, Yerby M, et al. Comparative safety of antiepileptic drugs during pregnancy. Neurology 2012, 78:1692-1699.
4. Tomson T., Battino D., Bonizzoni E., Craig J, Lindhout D, Sabers A, et al. Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry. Lancet Neurol 2011, 10:609-617.
5. Meador K.J., Baker G.A., Browning N., Cohen MJ, Bromley RL, Clayton-Smith J, et al. Fetal antiepileptic drug exposure and cognitive outcomes at age 6years (NEAD study): a prospective observational study. Lancet Neurol 2013, 12(3):244-252.
6. Pennell P.B. Antiepileptic drug pharmacokinetics during pregnancy and lactation. Neurology 2003, 61(Suppl. 2):S35-S42.
7. Leppik I.E., Rask C.A. Pharmacokinetics of antiepileptic drugs during pregnancy. Semin Neurol 1988, 8(3):240-246.
8. Pennell P.B., Peng L., Newport D.J., Ritchie JC, Koganti A, Holley DK, et al. Lamotrigine in pregnancy: clearance, therapeutic drug monitoring, and seizure frequency. Neurology 2008, 70:2130-2136.
9. Yerby M.S., Friel P.N., Miller D.Q. Carbamazepine protein binding and disposition in pregnancy. Ther Drug Monit 1985, 7:269-273.
10. Dam M., Christiansen J., Munck O., Mygind KI. Antiepileptic drugs: metabolism in pregnancy. Clin Pharmacokinet 1979, 4:53-62.
11. Battino D., Binelli S., Bossi L., Canger R, Croci D, Cusi C, et al. Plasma concentrations of carbamazepine and carbamazepine 10,11-epoxide during pregnancy and after delivery. Clin Pharmacokinet 1985, 10:279-284.
12. Tomson T., Lindbom U., Ekgvist B., Sundqvist A. Epilepsy and pregnancy: a prospective study of seizure control in relation to free and total plasma concentrations of carbamazepine and phenytoin. Epilepsia 1994, 35(1):122-130.
13. Yerby M.S., Friel P.N., McCormick K. Antiepileptic drug disposition during pregnancy. Neurology 1992, 42(4 Suppl. 5):12-16.
14. Harden C.L., Meador K.J., Pennell P.B., Hauser WA, Gronseth GS, French JA, et al. Practice parameter update: management issues for women with epilepsy-focus on pregnancy (an evidence-based review): teratogenesis and perinatal outcomes: Report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society. Neurology 2009, 73:133-141.
15. Reisinger T.L., Newman M., Loring D.W., Pennell PB, Meador KJ. Antiepileptic drug clearance and seizure frequency during pregnancy in women with epilepsy. Epilepsy Behav 2013, 29:13-18.
16. Battino D., Tomson T., Bonizzoni E., Craig J, Lindhout D, Sabers A, et al. Seizure control and treatment changes in pregnancy: observations from the EURAP epilepsy pregnancy registry. Epilepsia 2013, 54(9):1621-1627.
17. Blackburn S.T. Maternal, fetal, and neonatal physiology: a clinical perspective 2013, Elsevier Saunders, Maryland Heights. 4th ed.